Published in J Biol Chem on December 10, 1983
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Promoter of the pertussis toxin operon and production of pertussis toxin. J Bacteriol (1987) 1.98
Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol (1989) 1.64
Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun (1993) 1.62
Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med (1985) 1.54
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med (1989) 1.49
Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect Immun (1987) 1.48
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect Immun (1990) 1.44
Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant. Proc Natl Acad Sci U S A (1988) 1.40
Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin. Proc Natl Acad Sci U S A (1985) 1.39
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis. Infect Immun (1991) 1.35
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
Antibodies against the carboxyl-terminal 5-kDa peptide of the alpha subunit of transducin crossreact with the 40-kDa but not the 39-kDa guanine nucleotide binding protein from brain. Proc Natl Acad Sci U S A (1985) 1.30
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med (1990) 1.30
Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog (2006) 1.26
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun (1990) 1.19
Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism. Infect Immun (1995) 1.16
Pertussis toxin differentiates between two mechanisms of attenuation of cyclic AMP accumulation by muscarinic cholinergic receptors. Proc Natl Acad Sci U S A (1984) 1.16
Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev (1988) 1.16
Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose. Infect Immun (1987) 1.14
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Characterization of environmental regulators of Bordetella pertussis. Infect Immun (1993) 1.12
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10
A pertussis toxin-sensitive GTP-binding protein in the human neutrophil regulates multiple receptors, calcium mobilization, and lectin-induced capping. Proc Natl Acad Sci U S A (1985) 1.09
G(i/o) protein-dependent and -independent actions of Pertussis Toxin (PTX). Toxins (Basel) (2011) 1.08
Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun (1984) 1.07
Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping. Infect Immun (1989) 1.05
Characterization of serological responses to pertussis. Clin Vaccine Immunol (2006) 1.04
G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons. J Neurosci (1989) 1.03
Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun (2001) 1.03
Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids. Infect Immun (1989) 1.00
Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis. J Clin Microbiol (1990) 0.99
Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases. Microbiol Rev (1987) 0.98
Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin). Infect Immun (1987) 0.97
Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine. Infect Immun (2001) 0.95
Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin. Infect Immun (1992) 0.95
Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect Immun (1984) 0.95
Rat fat-cells have three types of adenosine receptors (Ra, Ri and P). Differential effects of pertussis toxin. Biochem J (1985) 0.95
Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis (2012) 0.94
Interaction of pertussis toxin with human T lymphocytes. Infect Immun (1992) 0.90
Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol (2002) 0.89
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis (2006) 0.88
T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One (2010) 0.87
Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1. Biochem J (2005) 0.86
Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis. J Clin Microbiol (1990) 0.85
New, practical approach to detecting antibody to pertussis toxin for public health and clinical laboratories. J Clin Microbiol (1988) 0.85
Role of a pertussis toxin substrate in the control of lectin-induced cap formation in human neutrophils. Biochem J (1986) 0.84
Biochemical and biological activities of recombinant S1 subunit of pertussis toxin. Infect Immun (1990) 0.84
Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol (2010) 0.83
Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography. Infect Immun (1987) 0.83
Development of a rapid diagnostic test for pertussis: direct detection of pertussis toxin in respiratory secretions. J Clin Microbiol (1989) 0.82
Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+. Biochem J (1990) 0.82
Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells. Clin Vaccine Immunol (2014) 0.82
Purification and characterization of the heat-labile toxin of Bordetella pertussis. Infect Immun (1991) 0.82
Does the guanine nucleotide regulatory protein Ni mediate progesterone inhibition of Xenopus oocyte adenylate cyclase? EMBO J (1984) 0.82
Laboratory Diagnosis of Pertussis. Clin Microbiol Rev (2015) 0.81
Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens. Clin Vaccine Immunol (2011) 0.79
Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum. J Clin Microbiol (1992) 0.79
Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction. J Clin Microbiol (1990) 0.79
Cross-talk between glucagon- and adenosine-mediated signalling systems in rat hepatocytes: effects on cyclic AMP-phosphodiesterase activity. Biochem J (1995) 0.79
Mass spectrometric analysis of multiple pertussis toxins and toxoids. J Biomed Biotechnol (2010) 0.79
Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin. Infect Immun (1990) 0.78
Cap formation in a B-lymphocyte cell line is inhibited by pertussis toxin and phorbol ester. Immunology (1987) 0.78
Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories. J Clin Microbiol (1989) 0.78
Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine. J Clin Microbiol (1989) 0.78
Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli. Infect Immun (1992) 0.78
Homologous beta-adrenergic desensitization in isolated rat hepatocytes. Biochem J (1987) 0.77
Pertussis toxin substrate is a guanosine 5'-[beta-thio]diphosphate-, N-ethylmaleimide-, Mg2+- and temperature-sensitive GTP-binding protein. Biochem J (1985) 0.77
Identification of B-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1993) 0.77
Confocal microscopy study of pertussis toxin and toxoids on CHO-cells. Hum Vaccin Immunother (2013) 0.75
Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin. Appl Environ Microbiol (2003) 0.75
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells. N Engl J Med (1975) 3.81
Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J (1988) 3.61
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
ADP-ribosylation of membrane components by pertussis and cholera toxin. Methods Enzymol (1985) 1.84
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA (1992) 1.60
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency. Trans Assoc Am Physicians (1976) 1.59
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma. Fed Proc (1976) 1.46
An antimicrobial peptide gene found in the male reproductive system of rats. Science (2001) 1.45
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Circulation (1999) 1.40
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice. J Immunol (1982) 1.31
Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide. J Pediatr (1988) 1.25
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Reconstitution of somatostatin and muscarinic receptor mediated stimulation of K+ channels by isolated GK protein in clonal rat anterior pituitary cell membranes. Mol Endocrinol (1987) 1.19
Effects of guanine nucleotides and Mg on human erythrocyte Ni and Ns, the regulatory components of adenylyl cyclase. J Biol Chem (1984) 1.18
Genotyping of human cystic echinococcosis in Xinjiang, PR China. Parasitology (2006) 1.17
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res (2000) 1.15
Coupling of the thyrotropin-releasing hormone receptor to phospholipase C by a GTP-binding protein distinct from the inhibitory or stimulatory GTP-binding protein. J Biol Chem (1986) 1.13
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
Levels of bovine papillomavirus RNA and protein expression correlate with variations in the tumorigenic phenotype of hamster cells. J Virol (1987) 1.13
Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymoma. Trans Assoc Am Physicians (1975) 1.13
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies. Arthritis Rheum (1981) 1.12
Identification and characterization of putative virulence genes and gene clusters in Aeromonas hydrophila PPD134/91. Appl Environ Microbiol (2005) 1.11
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Primate epididymis-specific proteins: characterization of ESC42, a novel protein containing a trefoil-like motif in monkey and human. Endocrinology (2001) 1.10
Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. J Biol Chem (2001) 1.10
Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun (1990) 1.08
Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun (1984) 1.07
Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res (1978) 1.06
Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr (1989) 1.05
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Phenol sulfotransferases. J Biol Chem (1979) 1.03
Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand (1985) 1.02
Prevalence of drug misuse among young people in Glasgow 1970-72. Br J Addict Alcohol Other Drugs (1974) 1.02
Pertussis vaccine research. Bull World Health Organ (1981) 0.99
Altered activity of the inhibitory guanyl nucleotide-binding component (Ni) induced by pertussis toxin. Uncoupling of Ni from receptor with continued coupling of Ni to the catalytic unit. J Biol Chem (1984) 0.99
Adenosine diphosphate ribosylation of G proteins by pertussis and cholera toxin in isolated membranes. Different requirements for and effects of guanine nucleotides and Mg2+. Mol Endocrinol (1987) 0.99
Mechanisms in the vectorial receptor-adenylate cyclase signal transduction. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.98
A protein activator for the adenylate cyclase of Bordetella pertussis. J Biol Chem (1979) 0.98
Adenyl cyclase in Bordetella pertussis vaccines. J Infect Dis (1977) 0.97
Aryl sulfotransferases. Methods Enzymol (1981) 0.97
Dual effects of pertussis toxin on lymphoid cells in culture. Cell Immunol (1986) 0.96
Regulation of prostatic steroid binding protein mRNAs by testosterone. Mol Cell Endocrinol (1985) 0.96
Characterization of phytoene synthase 1 gene (Psy1) located on common wheat chromosome 7A and development of a functional marker. Theor Appl Genet (2007) 0.96
Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect Immun (1984) 0.95
Pertussis toxin blocks melatonin-induced pigment aggregation in Xenopus dermal melanophores. J Comp Physiol B (1987) 0.95
Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J (1989) 0.94
Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol (1989) 0.93
The interaction of nucleotides with pertussis toxin. Direct evidence for a nucleotide binding site on the toxin regulating the rate of ADP-ribosylation of Ni, the inhibitory regulatory component of adenylyl cyclase. J Biol Chem (1986) 0.93
Evaluation of a ribosomal vaccine against pertussis. Infect Immun (1979) 0.93
Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF. J Biol Stand (1975) 0.92
Nuclear calcium gradients in cultured rat hepatocytes. Am J Physiol (1991) 0.92
Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells. J Pharmacol Exp Ther (1985) 0.92
Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 0.92
Responses of rice cultivars with different nitrogen use efficiency to partial nitrate nutrition. Ann Bot (2007) 0.90
Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha. Biochemistry (1999) 0.90
A comparison of gas-liquid chromatographic retention indices on support-coated open tubular columns and on packed columns for a series of central nervous stimulant drugs. J Chromatogr (1973) 0.90